Track genome-wide copy number variation

for safer cell therapy development and better insights into cancer drivers.

Speak to scientist

Multiple Myelomaс

Introducing Tapestri Single-cell Multiomics Solution for Multiple Myeloma

Get determinative insights into clonal heterogeneity driving disease progression and therapy response in multiple myeloma, even at its earliest stages.

Learn More

Genome Editing/Translocation

Develop Safer CRISPR-based Advanced Therapies with the Genome Editing Solution

Reveal the heterogeneity of gene edits at single-cell resolution, including on- and off-target edits, translocations, and zygosity of edits.

Learn More

PAD

Pharma Assay Development Services – Your Single-cell Technology Partner Across Therapeutic Development and Manufacturing

From drug development and clinical research to commercial manufacturing and release testing, PAD provides end-to-end support to accelerate your precision medicine and cell and gene therapy programs.

Learn More

LATEST

Mission Bio and Integrated DNA Technologies Partner to Advance Single-Cell Precision in CRISPR Genome Editing Analysis

CAPABILITIES

DNA Is Our Foundation

Providing cancer researchers with the only single-cell technology that simultaneously measures single nucleotide variation (SNV), copy number variation (CNV), and protein data from the same cells. Our multi-omics platform connects genotype and phenotype in each cell, dissecting the architecture of tumors with unprecedented resolution.

Single-cell Genomics (DNA)

SNV

Leverage single-cell technology to detect rare clonal populations and identify co-occurrence and zygosity.

LEARN MORE

SNV + CNV

Characterize genetic and copy number aberrations using a single comprehensive platform.

LEARN MORE

Single-cell Multi-omics (DNA + Protein)

DNA + Protein

Gain a true multi-omics picture from genotype to phenotype.

LEARN MORE

APPLICATIONS

Hematologic Malignancies

Clonal evolution impacts response, resistance, relapse, and residual disease.

LEARN MORE

Solid Tumors

Profiling enables high resolution of genomic diversity in a variety of tumor types.

LEARN MORE

Genome Editing

Single-cell technology provides quality control, ensuring the appropriate edits are incorporated.

LEARN MORE

PRODUCTS

The Tapestri Platform

The first and only single-cell technology developed to reveal biomarkers that help stratify patients, signal resistance, and predict relapse. Tapestri’s powerful multi-omics capability — connecting genotype and phenotype — opens the door to a deeper understanding and improved treatment of cancer.